NutriBrain: Protocol for a Randomised, Double-blind, Controlled Trial to Evaluate the Effects of a Nutritional Product on Brain Integrity in Preterm Infants

Overview

Journal BMC Pediatr

Publisher Biomed Central

Specialty Pediatrics

Date 2021 Mar 18

PMID 33731062

Citations 1

Authors

Lisa M Hortensius

Edith H van den Hooven

Jeroen Dudink

Maria Luisa Tataranno

Ruurd M van Elburg

Manon J N L Benders

Affiliations

Soon will be listed here.

Abstract

Background: The gut microbiota and the brain are connected through different mechanisms. Bacterial colonisation of the gut plays a substantial role in normal brain development, providing opportunities for nutritional neuroprotective interventions that target the gut microbiome. Preterm infants are at risk for brain injury, especially white matter injury, mediated by inflammation and infection. Probiotics, prebiotics and L-glutamine are nutritional components that have individually already demonstrated beneficial effects in preterm infants, mostly by reducing infections or modulating the inflammatory response. The NutriBrain study aims to evaluate the benefits of a combination of probiotics, prebiotics and L-glutamine on white matter microstructure integrity (i.e., development of white matter tracts) at term equivalent age in very and extremely preterm born infants.

Methods: This study is a double-blind, randomised, controlled, parallel-group, single-center study. Eighty-eight infants born between 24 + 0 and < 30 + 0 weeks gestational age and less than 72 h old will be randomised after parental informed consent to receive either active study product or placebo. Active study product consists of a combination of Bifidobacterium breve M-16V, short-chain galacto-oligosaccharides, long-chain fructo-oligosaccharides and L-glutamine and will be given enterally in addition to regular infant feeding from 48 to 72 h after birth until 36 weeks postmenstrual age. The primary study outcome of white matter microstructure integrity will be measured as fractional anisotropy, assessed using magnetic resonance diffusion tensor imaging at term equivalent age and analysed using Tract-Based Spatial Statistics. Secondary outcomes are white matter injury, brain tissue volumes and cortical morphology, serious neonatal infections, serum inflammatory markers and neurodevelopmental outcome.

Discussion: This study will be the first to evaluate the effect of a combination of probiotics, prebiotics and L-glutamine on brain development in preterm infants. It may give new insights in the development and function of the gut microbiota and immune system in relation to brain development and provide a new, safe treatment possibility to improve brain development in the care for preterm infants.

Trial Registration: ISRCTN, ISRCTN96620855 . Date assigned: 10/10/2017.

Citing Articles

The role of Klebsiella populations in preterm infants.

McCartney A, Hoyles L Biochem Soc Trans. 2023; 51(2):887-896.

PMID: 37099394 PMC: 10212511. DOI: 10.1042/BST20200325.

References

Neu J, DeMarco V, Li N . Glutamine: clinical applications and mechanisms of action. Curr Opin Clin Nutr Metab Care. 2002; 5(1):69-75. DOI: 10.1097/00075197-200201000-00013. View

Ball G, Counsell S, Anjari M, Merchant N, Arichi T, DOria V . An optimised tract-based spatial statistics protocol for neonates: applications to prematurity and chronic lung disease. Neuroimage. 2010; 53(1):94-102. DOI: 10.1016/j.neuroimage.2010.05.055. View

Mayer E . Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011; 12(8):453-66. PMC: 3845678. DOI: 10.1038/nrn3071. View

Vaughn P, Thomas P, Clark R, Neu J . Enteral glutamine supplementation and morbidity in low birth weight infants. J Pediatr. 2003; 142(6):662-8. DOI: 10.1067/mpd.2003.208. View

Mihatsch W, Hoegel J, Pohlandt F . Prebiotic oligosaccharides reduce stool viscosity and accelerate gastrointestinal transport in preterm infants. Acta Paediatr. 2006; 95(7):843-8. DOI: 10.1080/08035250500486652. View

Diaz Heijtz R, Wang S, Anuar F, Qian Y, Bjorkholm B, Samuelsson A . Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A. 2011; 108(7):3047-52. PMC: 3041077. DOI: 10.1073/pnas.1010529108. View

Isaacs E, Gadian D, Sabatini S, Chong W, Quinn B, Fischl B . The effect of early human diet on caudate volumes and IQ. Pediatr Res. 2008; 63(3):308-14. DOI: 10.1203/PDR.0b013e318163a271. View

Bravo J, Forsythe P, Chew M, Escaravage E, Savignac H, Dinan T . Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011; 108(38):16050-5. PMC: 3179073. DOI: 10.1073/pnas.1102999108. View

de Kieviet J, Oosterlaan J, Vermeulen R, Pouwels P, Lafeber H, van Elburg R . Effects of glutamine on brain development in very preterm children at school age. Pediatrics. 2012; 130(5):e1121-7. DOI: 10.1542/peds.2012-0928. View

10.

Izumi H, Minegishi M, Sato Y, Shimizu T, Sekine K, Takase M . Bifidobacterium breve alters immune function and ameliorates DSS-induced inflammation in weanling rats. Pediatr Res. 2015; 78(4):407-16. DOI: 10.1038/pr.2015.115. View

11.

Volpe J . Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol. 2008; 8(1):110-24. PMC: 2707149. DOI: 10.1016/S1474-4422(08)70294-1. View

12.

Yamashiro Y, Nagata S . Beneficial microbes for premature infants, and children with malignancy undergoing chemotherapy. Benef Microbes. 2011; 1(4):357-65. DOI: 10.3920/BM2010.0035. View

13.

Bermudez-Brito M, Plaza-Diaz J, Munoz-Quezada S, Gomez-Llorente C, Gil A . Probiotic mechanisms of action. Ann Nutr Metab. 2012; 61(2):160-74. DOI: 10.1159/000342079. View

14.

Davani-Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi S . Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications. Foods. 2019; 8(3). PMC: 6463098. DOI: 10.3390/foods8030092. View

15.

van Kooij B, de Vries L, Ball G, van Haastert I, Benders M, Groenendaal F . Neonatal tract-based spatial statistics findings and outcome in preterm infants. AJNR Am J Neuroradiol. 2011; 33(1):188-94. PMC: 7966173. DOI: 10.3174/ajnr.A2723. View

16.

Franz A, Pohlandt F, Bode H, Mihatsch W, Sander S, Kron M . Intrauterine, early neonatal, and postdischarge growth and neurodevelopmental outcome at 5.4 years in extremely preterm infants after intensive neonatal nutritional support. Pediatrics. 2009; 123(1):e101-9. DOI: 10.1542/peds.2008-1352. View

17.

Smith S, Nichols T . Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage. 2008; 44(1):83-98. DOI: 10.1016/j.neuroimage.2008.03.061. View

18.

Gasparrini A, Wang B, Sun X, Kennedy E, Hernandez-Leyva A, Ndao I . Persistent metagenomic signatures of early-life hospitalization and antibiotic treatment in the infant gut microbiota and resistome. Nat Microbiol. 2019; 4(12):2285-2297. PMC: 6879825. DOI: 10.1038/s41564-019-0550-2. View

19.

Chi C, Buys N, Li C, Sun J, Yin C . Effects of prebiotics on sepsis, necrotizing enterocolitis, mortality, feeding intolerance, time to full enteral feeding, length of hospital stay, and stool frequency in preterm infants: a meta-analysis. Eur J Clin Nutr. 2018; 73(5):657-670. PMC: 6760619. DOI: 10.1038/s41430-018-0377-6. View

20.

de Kieviet J, Vuijk P, van den Berg A, Lafeber H, Oosterlaan J, van Elburg R . Glutamine effects on brain growth in very preterm children in the first year of life. Clin Nutr. 2013; 33(1):69-74. DOI: 10.1016/j.clnu.2013.03.019. View